Long trade on Elixinol Global (EXL)This trade truly is the epitome of risk:reward. If you look at Creso Pharma (CPH) in October-December of 2020, you will note EXL is mirroring similar price action. What this means, is that EXL is literally trading at all-time lows, and this takes into consideration the 2020 Covid Crash. I am current
Key stats
Market capitalization
6.642MAUD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.033AUD
About ELIXINOL WELLNESS LIMITED
ISIN
AU000000EXL4
Sector
Health Technology
Industry
Pharmaceuticals: Other
Website
elixinolglobal.com
CEO
Ron Dufficy
Headquarters
Sydney
Founded
2017
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.
(OTC: ELLXF) Sell Elixinol Global & Aurora CannabisHey Cannabis Investors!
I recommended our paid members sell their Aurora Cannabis (NYSE: ACB) and Elixinol Global (OTC: ELLXF) holdings.
I am no longer confident in either company’s ability to weather a sustained downturn.
Aurora is struggling on all fronts.
And Aurora founder Terry Booth recen
Blame Canada for the Pot Stock CrashHappy 420!
When legal recreational cannabis sales began in Canada on Oct 17, 2018, marijuana companies and investors were brimming with confidence...
A large industrialized country had finally legalized marijuana. And with an adult population of nearly 30 million people, Canada would finally show
ASX:EXL - Bullish revenge in 2020? After forming a double top at the end of May last year, ASX:EXL has been bled down - dropping 90% (!!) from its all time highs. The bulls stepped in, providing some relief with 4 straight weeks of buying early this year. Can this be sustained?
Here's why I'm bullish:
Volume: High volume week,
ASX: Elixinol GlobalFactors
1. Price has moved out of the LT downtrend (Starting April 19)
2. Price closed the recent gap while slowly building a base.
3. EMA is converging and slowly crossing upwards
4. There is an overhead gap at $2.10 which I would be looking to target.
Possible Reasons For Failure
1. No bullish
Going Green in the Land Down Under!!Hey Friends!
Elixinol Global (OTC: ELLXF) primarily deals in hemp-based dietary supplements and skin care products. It also has a new medical marijuana brand called Nunyara...
The company started out as Elixinol Australia. It was a first mover in the cannabis-infused food world and is now a top do
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0